Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Change in Accured Expenses (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Change in Accured Expenses over the past 16 years, most recently at -$3.5 million for Q2 2025.

  • For Q2 2025, Change in Accured Expenses fell 159.96% year-over-year to -$3.5 million; the TTM value through May 2025 reached -$5.9 million, down 458.08%, while the annual FY2025 figure was -$5.9 million, 458.08% down from the prior year.
  • Change in Accured Expenses for Q2 2025 was -$3.5 million at Lifecore Biomedical, Inc. \De\, down from -$886000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $5.8 million in Q2 2024 and troughed at -$4.7 million in Q1 2023.
  • A 5-year average of -$839555.6 and a median of -$1.4 million in 2021 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: soared 453.73% in 2022 and later crashed 398.65% in 2023.
  • Year by year, Change in Accured Expenses stood at -$1.6 million in 2021, then soared by 453.73% to $5.6 million in 2022, then tumbled by 68.96% to $1.8 million in 2023, then plummeted by 172.02% to -$1.3 million in 2024, then crashed by 177.48% to -$3.5 million in 2025.
  • Business Quant data shows Change in Accured Expenses for LFCR at -$3.5 million in Q2 2025, -$886000.0 in Q1 2025, and -$1.3 million in Q4 2024.